Verena Bihrer

549 total citations
8 papers, 475 citations indexed

About

Verena Bihrer is a scholar working on Cancer Research, Molecular Biology and Hepatology. According to data from OpenAlex, Verena Bihrer has authored 8 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Hepatology. Recurrent topics in Verena Bihrer's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (2 papers) and Hepatitis B Virus Studies (2 papers). Verena Bihrer is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (2 papers) and Hepatitis B Virus Studies (2 papers). Verena Bihrer collaborates with scholars based in Germany, Bangladesh and Spain. Verena Bihrer's co-authors include Albrecht Piiper, Oliver Waidmann, Bernd Kronenberger, Stefan Zeuzem, Jörg Haupenthal, Nicole Forestier, Christoph Sarrazin, Yongyong Shi, Mireen Friedrich‐Rust and Heinfried H. Radeke and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Verena Bihrer

8 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Bihrer Germany 7 374 355 111 98 23 8 475
Shandong Pan China 8 282 0.8× 288 0.8× 152 1.4× 105 1.1× 80 3.5× 8 485
Rozanne C. de Veer Netherlands 7 129 0.3× 148 0.4× 74 0.7× 76 0.8× 26 1.1× 10 278
Zhihui Dai China 10 261 0.7× 373 1.1× 39 0.4× 18 0.2× 65 2.8× 17 485
Suki S. Lau Hong Kong 3 128 0.3× 264 0.7× 65 0.6× 28 0.3× 35 1.5× 3 367
Chunlai Yin China 9 155 0.4× 239 0.7× 68 0.6× 43 0.4× 155 6.7× 16 405
Liming Zhang China 8 289 0.8× 319 0.9× 25 0.2× 15 0.2× 28 1.2× 16 410
Yan Stein Israel 9 84 0.2× 200 0.6× 55 0.5× 29 0.3× 35 1.5× 12 353
Nan-Sheng Cheng China 9 97 0.3× 98 0.3× 76 0.7× 87 0.9× 8 0.3× 17 291
Yichuan Yuan China 8 102 0.3× 126 0.4× 54 0.5× 93 0.9× 25 1.1× 12 270
Guillaume Morcrette France 7 61 0.2× 117 0.3× 57 0.5× 85 0.9× 51 2.2× 13 343

Countries citing papers authored by Verena Bihrer

Since Specialization
Citations

This map shows the geographic impact of Verena Bihrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Bihrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Bihrer more than expected).

Fields of papers citing papers by Verena Bihrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Bihrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Bihrer. The network helps show where Verena Bihrer may publish in the future.

Co-authorship network of co-authors of Verena Bihrer

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Bihrer. A scholar is included among the top collaborators of Verena Bihrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Bihrer. Verena Bihrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Korkusuz, Hüdayi, et al.. (2012). Different signal intensity at Gd‐EOB‐DTPA compared with Gd‐DTPA‐enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging. Journal of Magnetic Resonance Imaging. 35(6). 1397–1402. 6 indexed citations
2.
Haupenthal, Jörg, Verena Bihrer, Hüdayi Korkusuz, et al.. (2012). Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels. Neoplasia. 14(5). 410–IN10. 44 indexed citations
3.
Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2012). 490 SERUM MICRORNA-122 LEVELS IN DIFFERENT GROUPS OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. Journal of Hepatology. 56. S193–S193. 7 indexed citations
4.
Korkusuz, Hüdayi, Verena Bihrer, Valery P. Chernikov, et al.. (2012). Contrast Enhancement of the Brain by Folate-Conjugated Gadolinium–Diethylenetriaminepentaacetic Acid–Human Serum Albumin Nanoparticles by Magnetic Resonance Imaging. Molecular Imaging. 11(4). 272–9. 10 indexed citations
5.
Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2011). Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis. 19(2). e58–65. 109 indexed citations
6.
Waidmann, Oliver, Verena Bihrer, Bernd Kronenberger, et al.. (2011). Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection. Digestive and Liver Disease. 44(5). 438–441. 14 indexed citations
7.
Bihrer, Verena, Oliver Waidmann, Mireen Friedrich‐Rust, et al.. (2011). Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma. PLoS ONE. 6(10). e26971–e26971. 116 indexed citations
8.
Bihrer, Verena, Mireen Friedrich‐Rust, Bernd Kronenberger, et al.. (2011). Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection. The American Journal of Gastroenterology. 106(9). 1663–1669. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026